Drug
Caffeine (6mg/kg)
Caffeine (6mg/kg) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
25%
Ph phase_3
1
25%
Ph not_applicable
2
50%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Not yet recruiting2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
not_yet_recruiting250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Placebo Effect on Cycling Performance: Laboratory Crossover Study
NCT07748429
not_yet_recruitingnot_applicable
Placebo Effect in Field-Based Physical Performance
NCT07742150
completedearly_phase_1
Caffeine Supplementation on Movement Patterns and Reactive Agility in Rugby Sevens Matches
NCT06612463
completedphase_3
Caffeine and Intermittent Claudication
NCT00388128
Clinical Trials (4)
Showing 4 of 4 trials
NCT07748429Not Applicable
Placebo Effect on Cycling Performance: Laboratory Crossover Study
NCT07742150Not Applicable
Placebo Effect in Field-Based Physical Performance
NCT06612463Early Phase 1
Caffeine Supplementation on Movement Patterns and Reactive Agility in Rugby Sevens Matches
NCT00388128Phase 3
Caffeine and Intermittent Claudication
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4